secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2026-06-03T12:31:58+00:00
Accession:  0001823239-26-000049
Event type: debt
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 1.02, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Maravai LifeSciences refinances credit agreement, reduces debt by ~$93M and extends maturity to 2032
--------------------------------------------------------------------------------

- New $150M term loan and $30M revolver mature June 2032; proceeds plus $98.5M cash repaid $242.9M prior debt due Oct 2027.
- Interest rate at Term SOFR + 5.00% (stepdown to 4.75% if first lien net leverage ≤ 3.0x).
- Financial covenant (max 6.5x leverage) applies only if revolver usage exceeds 40% of $30M commitment.
- Net debt reduced from $242.9M to $150.0M; revolver provides $30M additional liquidity.
- CFO Raj Asarpota cited strengthened financial foundation and preserved access to capital for growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323926000049/0001823239-26-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323926000049/mrvi-20260602.htm
  HTML page:      https://secwatch.observer/filing/0001823239-26-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer